Variational AI Releases Enki 4 Platform
Variational AI announced today (April 7, 2026) the release of Enki 4, a major update to its generative AI platform for small-molecule drug discovery. Enki 4 expands pre-trained target coverage from 592 to 760 targets (a 28% increase), extends support to degraders, PROTACs, glues and ADC payload design, and improves algorithmic performance across more than 12 target classes. The company says the platform accelerates generation of lead-like molecules for biotech partners.
Scoring Rationale
Official company announcement with credible claims and high actionability for drug-discovery teams; notable modality and target-coverage expansion increases practical value. Score slightly tempered by incremental novelty and limited technical detail in the release.
Practice interview problems based on real data
1,500+ SQL & Python problems across 15 industry datasets — the exact type of data you work with.
Try 250 free problemsStep-by-step roadmaps from zero to job-ready — curated courses, salary data, and the exact learning order that gets you hired.
Sources
- Read OriginalVariational AI Releases Enki 4: Major Update to Foundation Model for Small-Molecule Drug Discoverymontrealgazette.com
